| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Over the last 12 months, insiders at Minerva Neurosciences, Inc. have bought $0 and sold $0 worth of Minerva Neurosciences, Inc. stock.
On average, over the past 5 years, insiders at Minerva Neurosciences, Inc. have bought $20,790 and sold $96,106 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,000 shares for transaction amount of $20,790 was made by VAN HEEK G JAN (director) on 2020‑09‑10.
| 2023-05-02 | Sale | Luthringer Remy | CEO | 3,641 0.0559% | $3.76 | $13,690 | +44.12% | |
| 2023-05-01 | Sale | Luthringer Remy | CEO | 23,753 0.4554% | $3.85 | $91,449 | +75.93% | |
| 2023-05-01 | Sale | Race Geoff | President | 22,082 0.4234% | $3.85 | $85,016 | +75.93% | |
| 2023-05-01 | Sale | Ahlholm Frederick W | SVP, CFO and Secretary | 3,580 0.0799% | $4.48 | $16,038 | +75.93% | |
| 2021-12-01 | Sale | Kupfer David | director | 55,635 0.1267% | $0.88 | $48,959 | -24.72% | |
| 2020-12-16 | Sale | Race Geoff | EVP, CFO & CBO | 6,190 0.0149% | $2.64 | $16,342 | -10.31% | |
| 2020-12-16 | Sale | Luthringer Remy | CEO | 1,300 0.0031% | $2.64 | $3,432 | -10.31% | |
| 2020-12-16 | Sale | Reilly Joseph H. | SVP & Chief Operating Officer | 3,228 0.0078% | $2.64 | $8,522 | -10.31% | |
| 2020-12-16 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 1,845 0.0044% | $2.64 | $4,871 | -10.31% | |
| 2020-09-10 | VAN HEEK G JAN | director | 7,000 0.0171% | $2.97 | $20,790 | -0.86% | ||
| 2020-05-26 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 8,339 0.0216% | $15.00 | $125,085 | -78.03% | |
| 2019-12-17 | Sale | Race Geoff | EVP, CFO & CBO | 5,826 0.0152% | $7.10 | $41,365 | -46.98% | |
| 2019-12-17 | Sale | Luthringer Remy | CEO | 2,412 0.0063% | $7.10 | $17,125 | -46.98% | |
| 2019-12-17 | Sale | Reilly Joseph H. | SVP & Chief Operating Officer | 2,724 0.0071% | $7.10 | $19,340 | -46.98% | |
| 2019-12-17 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 1,557 0.0041% | $7.10 | $11,055 | -46.98% | |
| 2019-12-12 | Sale | Russell Richard E. | President | 3,113 0.0078% | $7.42 | $23,098 | -50.13% | |
| 2019-06-27 | DOYLE WILLIAM F | director | 3,500 0.009% | $5.50 | $19,250 | +23.53% | ||
| 2019-06-26 | Kupfer David | director | 10,000 0.0264% | $5.55 | $55,500 | +25.05% | ||
| 2019-06-26 | VAN HEEK G JAN | director | 10,000 0.0255% | $5.37 | $53,700 | +25.05% | ||
| 2019-06-26 | HASLER HANS PETER | director | 10,000 0.0266% | $5.60 | $56,000 | +25.05% |
| Ollier Michele | 4488272 64.1786% | $9.45M | 2 | 1 | <0.0001% | |
| De Rubertis Francesco | 4488272 64.1786% | $9.45M | 2 | 1 | <0.0001% | |
| Index Venture Associates III Ltd | 10 percent owner | 3899189 55.7552% | $8.21M | 2 | 18 | <0.0001% |
| JOHNSON & JOHNSON | 10 percent owner | 3892256 55.6561% | $8.19M | 2 | 0 | <0.0001% |
| Pellegrini Lorenzo | 3883212 55.5267% | $8.17M | 1 | 0 | <0.0001% | |
| Care Capital III LLC | 10 percent owner | 1662592 23.7737% | $3.5M | 1 | 7 | <0.0001% |
| Kupfer David | director | 163553 2.3387% | $344,279.07 | 4 | 1 | <0.0001% |
| Luthringer Remy | CEO | 68994 0.9866% | $145,232.37 | 0 | 8 | |
| Race Geoff | President | 51324 0.7339% | $108,037.02 | 1 | 7 | <0.0001% |
| Beer Marc D | director | 50000 0.715% | $105,250.00 | 2 | 0 | <0.0001% |
| Vivaldi Coelho Rogerio | President and CEO | 41667 0.5958% | $87,709.04 | 1 | 0 | <0.0001% |
| Russell Richard E. | President | 33770 0.4829% | $71,085.85 | 0 | 2 | |
| Reilly Joseph H. | SVP & Chief Operating Officer | 31747 0.454% | $66,827.44 | 1 | 7 | <0.0001% |
| DOYLE WILLIAM F | director | 26111 0.3734% | $54,963.66 | 11 | 0 | <0.0001% |
| VAN HEEK G JAN | director | 20333 0.2907% | $42,800.97 | 3 | 0 | <0.0001% |
| Ahlholm Frederick W | SVP, CFO and Secretary | 17518 0.2505% | $36,875.39 | 1 | 8 | <0.0001% |
| HASLER HANS PETER | director | 10000 0.143% | $21,050.00 | 1 | 0 | |
| HILLEMAN JERYL L | director | 1000 0.0143% | $2,105.00 | 1 | 0 | |
| Levine Mark S. | SVP,General Counsel & Sec. | 0 0% | $0 | 0 | 2 |
$1,848,072 | 66 | -14.67% | $11.93M | |
$395,438 | 43 | -21.25% | $16.52M | |
$1,018,029 | 34 | -26.34% | $11.81M | |
Minerva Neurosciences, Inc. (NERV) | $95,303,339 | 30 | -13.78% | $14.72M |
$523,320 | 24 | 94.37% | $11.81M | |
$226,127 | 22 | -27.62% | $15.87M | |
$555,628 | 21 | 43.52% | $16.96M | |
$114,405,653 | 19 | -5.40% | $15M | |
$8,079,884 | 14 | -43.20% | $11.56M | |
$941,975 | 12 | -10.74% | $11.7M | |
$389,864 | 11 | 12.52% | $15.42M | |
$11,777,042 | 10 | -11.94% | $16.65M | |
$70,584,874 | 10 | 3.97% | $14.5M | |
$36,538,405 | 10 | -21.99% | $13.91M | |
$2,889,596 | 6 | -43.43% | $14.5M | |
$2,060,158 | 5 | -21.35% | $16.99M | |
$82,917 | 4 | -11.54% | $16.95M | |
$31,190 | 2 | -14.18% | $17.66M | |
$19,863 | 1 | 144.27% | $13.31M |
| Increased Positions | 6 | +23.08% | 23,426 | +1.11% |
| Decreased Positions | 7 | -26.92% | 177,665 | -8.43% |
| New Positions | <1 | New | 25 | New |
| Sold Out Positions | 3 | Sold Out | 144,320 | Sold Out |
| Total Postitions | 25 | -3.85% | 2M | -7.32% |
| Federated Hermes, Inc. | $2,297.00 | 19.3% | 1.35M | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $429.00 | 3.6% | 252,060 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $218.00 | 1.83% | 128,100 | -29,100 | -18.51% | 2024-12-31 |
| Oconnor, A Distinct Business Unit Of Ubs Asset Management Am | $182.00 | 1.53% | 107,256 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $124.00 | 1.04% | 72,669 | 0 | 0% | 2025-03-31 |
| Geode Capital Management, Llc | $96.00 | 0.81% | 56,456 | 0 | 0% | 2024-12-31 |
| Northern Trust Corp | $63.00 | 0.53% | 36,878 | +13,829 | +60% | 2024-12-31 |
| Citadel Advisors Llc | $44.00 | 0.37% | 25,764 | +8,525 | +49.45% | 2024-12-31 |
| Apella Capital, Llc | $35.00 | 0.3% | 20,625 | +20,625 | New | 2025-03-31 |
| Acadian Asset Management Llc | $30.00 | 0.25% | 17,416 | 0 | 0% | 2024-12-31 |